Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Understanding why age matters in retirement savings can help you maximize your investments. Learn how to strategize based on your age.
22,430 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A major hedge fund just sold its entire Abercrombie & Fitch stake. Here’s what that means for investors, how to inter...
Berkshire Hathaway kicked off the year with bold portfolio changes. In Q1, the company swapped key holdings and redir...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...
Old homes are cash machines for savvy flippers, but growing bureaucratic delays complicate rehab plans. Learn where r...
Stocks rise as investors seek durable earnings power in blue-chip names. history says this unstoppable Dow juggernaut...
Apple rolled out a beta Siri upgrade with limited regional access, keeping EU and China on the sidelines. Investors a...
SpaceX’s IPO priced at $135 per share, raising $75 billion and signaling a landmark moment for tokenized equities as ...
Retail buyers piled into SpaceX shares over a two-day window, creating a record pace that outstripped every other U.S...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
A hard look at how scammers recruit money mules, the risks for seniors, and concrete steps you can take to shield you...
The IYE ETF sports a 2.2% yield while delivering a 131% gain over five years, a combination that challenges investors...